Search

everythinglearnresearchcommunity

for

Search:↓

Biotin deficiency causes severe hair loss and weight reduction in germ-free mice.

The conclusion is that different types of hair loss in dogs and cats can be cosmetic or serious, and affected animals should not be bred.

Nanotechnology shows promise in improving hair loss treatments by enhancing drug delivery and reducing side effects.

Experts created guidelines for treating hair loss in Egypt, focusing on personalized care.

Hair transplant surgery can successfully treat hair loss at the back of the neck.

Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.

The document concludes that permanent hair loss conditions are complex, require early specific treatments, and "secondary permanent alopecias" might be a more accurate term than "secondary cicatricial alopecia."

No FDA-approved treatments for chemotherapy-induced hair loss existed in 2006; more research was needed.

Oral minoxidil improved hair loss more than oral dutasteride.

Nanotechnology shows promise for treating hair loss but faces safety and approval challenges.

Secukinumab can cause hair loss, which may improve after stopping the medication.

COL17A1 is crucial for preventing hair graying and loss by supporting hair and pigment stem cells.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Understanding EGFR roles could lead to new hair loss treatments.

Combination therapies work better than single treatments for hair loss.

New 5% minoxidil formula safely and effectively treats male hair loss.

Hair follicle regeneration and delivery is complex due to many molecular and cellular factors.

Hair RiseTM microemulsion effectively promotes hair growth and treats hair loss better than standard treatments.

A 4-year-old girl with hair loss was diagnosed with early-onset trichotillomania and improved with behavioral interventions.

Cicatricial alopecia, a permanent hair loss condition, is mainly caused by damage to specific hair follicle stem cells and abnormal immune responses, with gene regulator PPAR-y and lipid metabolism disorders playing significant roles.

Alopecia areata involves immune response and gene changes affecting hair loss.

The best long-lasting results in treating hair loss may be achieved through combination therapy, including treatments like finasteride, minoxidil, and platelet-rich plasma injections.

Nanotechnology offers promising new treatments for hair loss by improving targeted delivery and addressing key causes.

Trichloroacetic acid is a safe and effective treatment for hair loss in alopecia areata patients.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

FoxN1 gene is essential for proper thymus structure and preventing hair loss.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

Ethosomes with 30% ethanol effectively deliver dutasteride to hair follicles for treating hair loss.

RORA affects hair follicle stem cells' structure and movement, potentially helping treat hair loss.

New hair can grow at wound sites, which could help improve treatments for hair loss and wound healing.